First Horizon Advisors Inc. boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,193 shares of the financial services provider’s stock after purchasing an additional […]
Investment House LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,946 shares of the financial services provider’s stock after selling 2,138 shares during […]
Bank of New Hampshire reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,607 shares of the financial services provider’s stock after selling 914 shares […]
Bank of New Hampshire reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,607 shares of the financial services provider’s stock after selling 914 shares during the quarter. Bank of New Hampshire’s holdings in iShares Biotechnology ETF were worth […]
SlateStone Wealth LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,356 shares of the financial services provider’s stock after acquiring an additional 906 shares during […]